In humans, mutations in either PMPCA or PMPCB cause mitochondrial diseases that are characterized by neurological disorders with early childhood onset and a severe neurodegenerative course [35,36,37] (Figure 3A,B). This evidence concerns the gene PMPCB and inborn mitochondrial metabolism disorder.